Technology | Flat Panel Displays | May 04, 2016

Multimodality monitor now approved for tomosynthesis, mammography and general radiography

Eizo, RadiForce RX850 multimodality monitor, FDA clearance, tomosynthesis

May 4, 2016 — Eizo Inc. recently announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis for its 8 megapixel multimodality monitor, the RadiForce RX850.

Digital breast tomosynthesis is a method of breast screening that allows the radiologist to view detailed three-dimensional images of the breast assembled from multiple X-ray pictures. When used in combination with digital mammography, tomosynthesis provides radiologists with multiple screening techniques that can be utilized together for increased diagnostic precision in breast cancer detection. The RadiForce RX850 now has FDA 510(k) approval in tomosynthesis, mammography and general radiography.

The RadiForce RX850’s super high-resolution screen (4096 x 2160) displays 8 megapixels of information with a pixel pitch of 0.1704 mm for viewing medical breast images in exceptional detail. To detect the smallest structures, the monitor offers a high contrast ratio of 1450:1. The deeper black levels distinguish similar shades of gray for sharper monochrome image reproduction.

For more information: www.eizo.com


Related Content

News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
News | Mammography

Sept. 30, 2024 — Siemens Healthineers recently announced the Food and Drug Administration’s premarket approval (PMA) for ...

Time September 30, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Artificial Intelligence

June 26, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced it ...

Time June 26, 2024
arrow
News | MRI Breast

June 12, 2024 — Royal Philips recently announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet ...

Time June 12, 2024
arrow
Subscribe Now